| 1 |
Blanco-Fernández G, Blanco-Fernandez B, Fernández-Ferreiro A, Otero-Espinar FJ. Lipidic lyotropic liquid crystals: Insights on biomedical applications. Adv Colloid Interface Sci 2023;313:102867. [PMID: 36889183 DOI: 10.1016/j.cis.2023.102867] [Reference Citation Analysis]
|
| 2 |
Gautam S, Marwaha D, Singh N, Rai N, Sharma M, Tiwari P, Urandur S, Shukla RP, Banala VT, Mishra PR. Self-Assembled Redox-Sensitive Polymeric Nanostructures Facilitate the Intracellular Delivery of Paclitaxel for Improved Breast Cancer Therapy. Mol Pharm 2023. [PMID: 36848489 DOI: 10.1021/acs.molpharmaceut.2c00673] [Reference Citation Analysis]
|
| 3 |
Lopes LB, Apolinário AC, Salata GC, Malagó ID, Passos JS. Lipid Nanocarriers for Breast Cancer Treatment. Cancer Nanotechnology 2023. [DOI: 10.1007/978-3-031-17831-3_1] [Reference Citation Analysis]
|
| 4 |
Vitoria Pupo Silvestrini A, Wender Debiasi B, Garcia Praça F, Vitoria Lopes Badra Bentley M. Progress and challenges of lyotropic liquid crystalline nanoparticles for innovative therapies. International Journal of Pharmaceutics 2022;628:122299. [DOI: 10.1016/j.ijpharm.2022.122299] [Reference Citation Analysis]
|
| 5 |
Sanap SN, Bisen AC, Mishra A, Biswas A, Agrawal S, Yadav KS, Krishna A, Chopra S, Mugale MN, Bhatta RS. QbD based antifungal drug-loaded ophthalmic liposomal formulation for the management of fungal keratitis: In vitro, ex vivo and in vivo pharmacokinetic studies. Journal of Drug Delivery Science and Technology 2022;74:103517. [DOI: 10.1016/j.jddst.2022.103517] [Reference Citation Analysis]
|
| 6 |
Singh A, Vaish A, Shukla R. Box-Behnken design optimized silibinin loaded glycerylmonooleate nanoliquid crystal for brain targeting. Chemistry and Physics of Lipids 2022;244:105193. [DOI: 10.1016/j.chemphyslip.2022.105193] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 7 |
Sharma M, Bakshi AK, Mittapelly N, Gautam S, Marwaha D, Rai N, Singh N, Tiwari P, Aggarwal N, Kumar A, Mishra PR. Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Saklani R, Yadav PK, Nengroo MA, Gawali SL, Hassan PA, Datta D, Mishra DP, Dierking I, Chourasia MK. An Injectable In Situ Depot-Forming Lipidic Lyotropic Liquid Crystal System for Localized Intratumoral Drug Delivery. Mol Pharm 2022. [PMID: 35191706 DOI: 10.1021/acs.molpharmaceut.1c00782] [Reference Citation Analysis]
|
| 9 |
Sharma M, Mittapelly N, Banala VT, Urandur S, Gautam S, Marwaha D, Rai N, Singh N, Gupta A, Mitra K, Mishra PR. Amalgamated Microneedle Array Bearing Ribociclib-Loaded Transfersomes Eradicates Breast Cancer via CD44 Targeting. Biomacromolecules 2022. [PMID: 34978424 DOI: 10.1021/acs.biomac.1c01076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Kamnoore D, Mukherjee D, Nayak Ammunje D, Parasuraman P, Teja BV, Radhika M. Hydroxyapatite nanoparticle-enriched thiolated polymer-based biocompatible scaffold can improve skin tissue regeneration. Journal of Materials Research 2021;36:4287-306. [DOI: 10.1557/s43578-021-00405-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Yao W, Liu C, Wang N, Zhou H, Chen H, Qiao W. Anisamide-modified dual-responsive drug delivery system with MRI capacity for cancer targeting therapy. Journal of Molecular Liquids 2021;340:116889. [DOI: 10.1016/j.molliq.2021.116889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Tripathi S, Gupta U, Ujjwal RR, Yadav AK. Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route. J Microencapsul 2021;38:572-93. [PMID: 34591731 DOI: 10.1080/02652048.2021.1986585] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Jalilian M, Derakhshandeh K, Kurd M, Lashani H. Targeting Solid Lipid Nanoparticles with Anisamide for Docetaxel Delivery to Prostate Cancer: Preparation, Optimization, and In-vitro Evaluation. Iran J Pharm Res 2021;20:327-38. [PMID: 34400962 DOI: 10.22037/ijpr.2020.113436.14302] [Reference Citation Analysis]
|
| 14 |
Srinivasa HT, Mohammad A. Influence of terminally attached branched alkyloxy chains on the mesophase behaviour of calamitic liquid crystals. Phase Transitions 2021;94:256-269. [DOI: 10.1080/01411594.2021.1931202] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Jaiswal S, Dutta P, Kumar S, Chawla R. Chitosan modified by organo-functionalities as an efficient nanoplatform for anti-cancer drug delivery process. Journal of Drug Delivery Science and Technology 2021;62:102407. [DOI: 10.1016/j.jddst.2021.102407] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 16 |
Ma Y, Yu S, Ni S, Zhang B, Kung ACF, Gao J, Lu A, Zhang G. Targeting Strategies for Enhancing Paclitaxel Specificity in Chemotherapy. Front Cell Dev Biol 2021;9:626910. [PMID: 33855017 DOI: 10.3389/fcell.2021.626910] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 17 |
Kundu TK, Kulkarni AP, Datta D, Sikder S. Modern Drug Discovery and Development in the Area of Cancer: Indian Context. Drug Discovery and Drug Development 2021. [DOI: 10.1007/978-981-15-8002-4_10] [Reference Citation Analysis]
|
| 18 |
Yao W, Liu C, Wang N, Zhou H, Chen H, Qiao W. Triple-responsive targeted hybrid liposomes with high MRI performance for tumor diagnosis and therapy. Mater Chem Front 2021;5:6226-43. [DOI: 10.1039/d1qm00788b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Urandur S, Banala VT, Shukla RP, Gautam S, Marwaha D, Rai N, Sharma M, Sharma S, Ramarao P, Mishra PR. Theranostic lyotropic liquid crystalline nanostructures for selective breast cancer imaging and therapy. Acta Biomater 2020;113:522-40. [PMID: 32562804 DOI: 10.1016/j.actbio.2020.06.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 20 |
Ramzy L, Metwally AA, Nasr M, Awad GAS. Novel thymoquinone lipidic core nanocapsules with anisamide-polymethacrylate shell for colon cancer cells overexpressing sigma receptors. Sci Rep 2020;10:10987. [PMID: 32620860 DOI: 10.1038/s41598-020-67748-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 21 |
Singh A, Kumar A, Verma RK, Shukla R. Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity. Int J Biol Macromol 2020;149:1198-206. [PMID: 32044368 DOI: 10.1016/j.ijbiomac.2020.02.041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 22 |
Qu D, Jiao M, Lin H, Tian C, Qu G, Xue J, Xue L, Ju C, Zhang C. Anisamide-functionalized pH-responsive amphiphilic chitosan-based paclitaxel micelles for sigma-1 receptor targeted prostate cancer treatment. Carbohydrate Polymers 2020;229:115498. [DOI: 10.1016/j.carbpol.2019.115498] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 23 |
Gao M, Tang BZ. AIE-based cancer theranostics. Coordination Chemistry Reviews 2020;402:213076. [DOI: 10.1016/j.ccr.2019.213076] [Cited by in Crossref: 94] [Cited by in F6Publishing: 64] [Article Influence: 31.3] [Reference Citation Analysis]
|
| 24 |
Li Y, Angelova A, Hu F, Garamus VM, Peng C, Li N, Liu J, Liu D, Zou A. pH Responsiveness of Hexosomes and Cubosomes for Combined Delivery of Brucea javanica Oil and Doxorubicin. Langmuir 2019;35:14532-42. [PMID: 31635451 DOI: 10.1021/acs.langmuir.9b02257] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 25 |
Madheswaran T, Kandasamy M, Bose RJ, Karuppagounder V. Current potential and challenges in the advances of liquid crystalline nanoparticles as drug delivery systems. Drug Discovery Today 2019;24:1405-12. [DOI: 10.1016/j.drudis.2019.05.004] [Cited by in Crossref: 58] [Cited by in F6Publishing: 78] [Article Influence: 14.5] [Reference Citation Analysis]
|
| 26 |
Santhosh S, Mukherjee D, Anbu J, Murahari M, Teja BV. Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies. Journal of Microencapsulation 2019;36:338-55. [DOI: 10.1080/02652048.2019.1631401] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 27 |
Singh A, Vaishagya K, K Verma R, Shukla R. Temperature/pH-Triggered PNIPAM-Based Smart Nanogel System Loaded With Anastrozole Delivery for Application in Cancer Chemotherapy. AAPS PharmSciTech 2019;20:213. [PMID: 31165298 DOI: 10.1208/s12249-019-1410-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 28 |
Ma Y, Zhang Y, Liu X, Zhang Q, Kong L, Tian Y, Li G, Zhang X, Yang J. AIE-active luminogen for highly sensitive and selective detection of picric acid in water samples: Pyridyl as an effective recognition group. Dyes and Pigments 2019;163:1-8. [DOI: 10.1016/j.dyepig.2018.11.034] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 29 |
Song Z, Wang J, Liu R, He G, Tang M, Zhu H. Solvent-induced aggregation based on a heteroleptic Ir(iii) complex via hydrogen bonds. J Mater Chem C 2019;7:6941-6949. [DOI: 10.1039/c9tc01299k] [Reference Citation Analysis]
|
| 30 |
Urandur S, Marwaha D, Gautam S, Banala VT, Sharma M, Mishra PR. Nonlamellar liquid crystals: a new paradigm for the delivery of small molecules and bio-macromolecules. Therapeutic Delivery 2018;9:667-89. [DOI: 10.4155/tde-2018-0038] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
